Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the identification and validation of molecular and inflammatory markers associated with metabolic syndrome and Type 2 diabetes. Researchers are invited to present studies that elucidate the pathophysiological mechanisms underlying these conditions.
This session will explore the latest advancements in pharmacotherapy for diabetes, including new drug treatments and therapeutic strategies. Discussions will encompass both Type 1 and Type 2 diabetes management.
This track highlights the development of novel insulin delivery devices, including insulin pumps and pens. Presentations will cover the engineering, usability, and clinical outcomes associated with these innovations.
This session will delve into the development and implementation of artificial beta cells and biostators as closed-loop systems for diabetes management. Researchers will discuss the efficacy and future prospects of these technologies.
This track addresses the unique challenges and management strategies for diabetes in pediatric patients and during pregnancy. Studies focusing on gestational hyperglycemia and its long-term implications will also be featured.
This session will cover the complexities of autoimmune diabetes mellitus and monogenic forms of diabetes. Researchers are encouraged to share insights into genetic predispositions and novel treatment approaches.
This track focuses on the complications arising from diabetes, including cardiovascular, renal, and neuropathic issues. Presenters will discuss prevention strategies and management protocols to mitigate these complications.
This session will explore clinical methodologies for diagnosing and managing diabetes effectively. Emphasis will be placed on patient-oriented case management and evidence-based practices.
This track invites discussions on the application of computational methods in diabetes research, including data analytics and modeling. Researchers will present innovative approaches to understanding diabetes pathophysiology.
This session will address the regulatory frameworks and economic factors influencing diabetes research and treatment. Participants will explore the implications of policy on innovation and patient access.
This track will focus on the advancement of new drug and biomarker discovery for diabetes treatment. Researchers are invited to present their findings on emerging biomarkers and their potential clinical applications.